MYCO Profile
- Sector: Health Technology
- Industry: Pharmaceuticals
Mydecine Innovations Group, Inc. is a life sciences company dedicated to the development and commercialization of adaptive pathway medicines, natural health products and digital health solutions. The company encompasses three companies: Mindleap Health, Mydecine Health Sciences, and NeuroPharm Inc. The Mindleap Health is an advanced digital health platform that helps people connect with mental health specialists who can empower them to thrive and develop habits for a healthy mind. The Mydecine Health Sciences is a vertically integrated company developing novel fungtional mushroom products and psychedelic medicines for healthy and vulnerable populations. The NeuroPharm is developing a unique and proprietary set of pharmaceutical and natural health products addressing mental wellness in vulnerable populations. The company was founded by Parente Carman on September 27, 2013 and is headquartered in Vancouver, Canada.
https://s3.tradingview.com/external-embedding/embed-widget-mini-symbol-overview.js https://s3.tradingview.com/external-embedding/embed-widget-financials.jsRecent News
- Naturally Splendid Prepares to Receive Third Container of NATERA Plant Based Foods
- Cresco Labs Announces Proposed Offering of Subordinate Voting Shares
- Columbia Care Receives Provisional License for Adult Use at its Patriot Care Dispensary in Downtown Boston
- MediPharm Labs Appoints Warren Everitt, CEO Australia Pacific, to Board of DirectorsWa
- Village Farms International Announces US$135 Million Registered Direct Offering
- Namaste Technologies Announces Bought Deal Public Offering
- Aurora Announces Agreement with Great North Distributors Inc. For Canadian Retail Sales Execution
- Cresco Labs to Expand Into Florida Through Acquisition of Bluma Wellness Inc.
- Body and Mind Provides Corporate Update
- PeakBirch Logic Expands CBD Sales into B2B with Collaborative Agreement with Namaste Technologies
